The Role of Urotensin Receptors in the Paracetamol‐Induced Hepatotoxicity Model in Mice: Ameliorative Potential of Urotensin II Antagonist
- 13 August 2015
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 118 (2), 150-159
- https://doi.org/10.1111/bcpt.12447
Abstract
We aimed to evaluate the possible protective effect of a UTR antagonist and to determine the effect of the antagonist on ALT and AST levels in serum, the mRNA expression level of UTR, tumour necrosis factor-alpha (TNF-) and IL-1 and SOD activity, GSH and MDA levels in liver tissues, which are important mediators or markers for the hepatotoxicity animal model in mice. Animals fasted overnight and were divided into seven equal groups (n=12). The first group was the healthy group (administered 0.1% DMSO intraperitoneally). Group 2 received only paracetamol (PARA) (administered orally at a dosage of 300mg/kg). Groups 3 and 4 were treated with only AGO (AC7954, UTR agonist) 15 and 30mg/kg intraperitoneally, respectively. Groups 5 and 6 were treated with only ANTA (SB657510, UTR antagonist) 30 and 60mg/kg intraperitoneally, respectively. Group 7 was treated with AGO 30mg/kg and ANTA 60mg/kg intraperitoneally. One hour after the pre-treatment drugs were administered, groups 3 through 7 were given PARA. After the experimental period, the mice were killed 6 and 24hr after PARA was administered. Antagonist administration significantly decreased the ALT and AST levels, while agonist administration did not. In addition, SOD activity and GSH levels increased, and the MDA level decreased with the pre-treatment of two antagonist doses. The increased UTR gene expression through PARA was significantly lower in both doses of the antagonist groups at 24hr when compared with the agonist and PARA groups. This study showed that UTR antagonists have hepatoprotective and anti-inflammatory effects on high-dose PARA-induced hepatotoxicity in mice.Keywords
Funding Information
- Scientific Research Council of Atatürk University (2013/025)
This publication has 56 references indexed in Scilit:
- Urotensin II Inhibits Skeletal Muscle Glucose Transport Signaling Pathways via the NADPH Oxidase PathwayPLOS ONE, 2013
- Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial CellsBiomolecules & Therapeutics, 2013
- Inhibition of UII/UTR System Relieves Acute Inflammation of Liver through Preventing Activation of NF-κB Pathway in ALF MicePLOS ONE, 2013
- Urotensin-II: More Than a Mediator for KidneyInternational Journal of Nephrology, 2012
- Hepatoprotective effect of ethanolic extract of Trichosanthes lobata on paracetamol-induced liver toxicity in ratsChinese Medicine, 2012
- Protective effects of natsumikan (Citrus natsudaidai) extract on acetaminophen-induced lethal hepatotoxicity in micePharmacognosy Research, 2012
- Expression of Urotensin II and Its Receptor in Human Liver Cirrhosis and Fulminant Hepatic FailureDigestive Diseases and Sciences, 2009
- Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney diseaseKidney International, 2008
- Tolerability of ParacetamolDrug Safety, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001